| Literature DB >> 26374880 |
Jonas Selmeryd1, Egil Henriksen2, Jerzy Leppert3, Pär Hedberg2.
Abstract
AIMS: The aim of this article is to examine how the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) recommendations on the classification of diastolic dysfunction (DDF) are interpreted in the scientific community and to explore how variations in the DDF definition affect the reported prevalence. METHODS ANDEntities:
Keywords: Diastolic dysfunction; Echocardiography; General population
Mesh:
Year: 2015 PMID: 26374880 PMCID: PMC4955290 DOI: 10.1093/ehjci/jev211
Source DB: PubMed Journal: Eur Heart J Cardiovasc Imaging ISSN: 2047-2404 Impact factor: 6.875
Variables used for DDF classification and grading grouped by different interpretations of the EACVI/ASE 2009 classification algorithm (n = 60)
| Variable | All ( | Algorithm interpretation specified ( | Algorithm interpretation not specified ( | ||
|---|---|---|---|---|---|
| Classification and grading of DDF by a one-level classification tree ( | Classification and grading of DDF by a two-level classification tree ( | Classification of DDF only, no grading ( | Classification and grading of DDF by unspecified algorithm ( | ||
| 44 (73%) | 13 (100%) | 16 (89%) | 3 (19%) | 12 (92%) | |
| Deceleration time | 37 (62%) | 9 (69%) | 14 (78%) | 2 (13%) | 12 (92%) |
| IVRT | 7 (12%) | 3 (23%) | 1 (6%) | 1 (6%) | 2 (15%) |
| Any | 28 (47%) | 1 (8%) | 16 (89%) | 3 (19%) | 8 (62%) |
| E′sep | 15 (25%) | 0 (0%) | 11 (61%) | 1 (6%) | 3 (23%) |
| E′lat | 14 (23%) | 1 (8%) | 7 (39%) | 2 (13%) | 4 (31%) |
| E′avg | 6 (10%) | 0 (0%) | 2 (11%) | 1 (6%) | 3 (23%) |
| | 2 (3%) | 0 (0%) | 2 (11%) | 0 (0%) | 0 (0%) |
| Any | 40 (67%) | 7 (54%) | 12 (67%) | 12 (75%) | 9 (69%) |
| | 5 (8%) | 1 (8%) | 1 (6%) | 2 (13%) | 1 (8%) |
| | 10 (17%) | 5 (38%) | 2 (11%) | 1 (6%) | 2 (15%) |
| | 21 (35%) | 0 (0%) | 6 (33%) | 10 (63%) | 5 (38%) |
| | 5 (8%) | 1 (8%) | 3 (17%) | 0 (0%) | 1 (8%) |
| Pulmonary flow indices | 8 (13%) | 6 (46%) | 0 (0%) | 0 (0%) | 2 (15%) |
| Left atrial size | 19 (32%) | 1 (8%) | 7 (39%) | 6 (38%) | 5 (38%) |
| LAVi | 16 (27%) | 1 (8%) | 6 (33%) | 6 (38%) | 3 (23%) |
| LAD or LAA | 3 (5%) | 0 (0%) | 1 (6%) | 0 (0%) | 2 (15%) |
| Valsalva reversal of | 3 (5%) | 2 (15%) | 0 (0%) | 0 (0%) | 1 (8%) |
S1–S60 denotes references available in Supplementary material online.
DDF, diastolic dysfunction; E, early diastolic inflow velocity; A, late diastolic inflow velocity; E′, early diastolic myocardial tissue velocity; E′sep, E′ of the septal wall; E′lat, E′ of the lateral wall; E′avg, averaged E′; LAVi, left atrial volume index; LAD, left atrial diameter; LAA, left atrial area.
Combinations of variables used for DDF classification and grading grouped by different interpretations of the EACVI/ASE 2009 classification algorithm in studies in which the algorithm interpretation was specified (n = 47)
| Classification and grading of DDF by a one-level classification tree | Classification and grading of DDF by a two-level classification tree | Classification of DDF only, no grading |
|---|---|---|
| For the definition of DDF and grading: | For the definition of DDF: | For the definition of DDF: |
| | | |
| | | LA size and |
| | | DT and IVRT ( |
| | | |
| | | |
| | LA size ( | |
| | For the subsequent grading of DDF: | LA size, |
| | | |
| | | |
| DT ( | ||
| | ||
| | ||
| | ||
| | ||
| Variables used not specified ( | ||
S1–S60 denotes references available in Supplementary material online.
DDF, diastolic dysfunction; E′, septal, lateral, average, or unspecified early myocardial tissue velocity; E, early transmitral flow velocity; A, late/atrial transmitral flow velocity; LA size, left atrial volume, diameter, or area; DT, deceleration time; IVRT, isovolumetric relaxation time; VSr, Valsalva reversal of E/A; PV, pulmonary venous flow indices.
Detailed definitions of DDF, including used logical operators, in studies in which DDF classification was based on E′ and/or left atrial size only (n = 17)
| E′sep < 8 OR E′lat < 10 OR LAVi > 34 ( |
| E′sep < 8 ( |
| E′lat < 10 ( |
| E′avg < 9 ( |
| E′sep < 8 AND E′lat < 10 AND LAVi > 34 ( |
| E′sep < 8 OR E′lat < 10 ( |
| E′ns < 8 ( |
| E′sep < 8 OR LAVi > 34 ( |
| LAVi > 34 ( |
| E′avg < 9 OR LAVi > 34 ( |
| E′sep < 8 AND E′lat < 10 ( |
S1–S60 denotes references available in Supplementary material online.
DDF, diastolic dysfunction; E′, early diastolic myocardial tissue velocity; E′sep, E′ of the septal wall; E′lat, E′ of the lateral wall; E′avg, average E′ of lateral and septal walls; E′ns, E′ of the unspecified wall; LAVi, left atrial volume index.
Basic characteristics of the study population
| All subjects ( | Low-risk subgroup ( | High-risk subgroup ( | ||
|---|---|---|---|---|
| Clinical characteristics | ||||
| Age (years) | 66.1 (±9.5) | 61.3 (±9.3) | 69.0 (±8.3) | <0.001 |
| Male sex | 493 (71%) | 102 (79%) | 228 (69%) | 0.05 |
| Body mass index (kg/m2) | 26.5 (±3.6) | 24.9 (±2.5) | 27.2 (±3.9) | <0.001 |
| Systolic blood pressure (mmHg) | 144.5 (±20.2) | 126.5 (±8.7) | 147.3 (±19.5) | <0.001 |
| Diastolic blood pressure (mmHg) | 79.4 (±9.5) | 74.2 (±6.7) | 79.0 (±9.5) | <0.001 |
| NT-proBNP (pg/mL) | 75 (40–146) | 51 (29–74) | 101 (57–206) | <0.001 |
| NT-proBNP > 125 (pg/mL) | 204 (29%) | 0 (0%) | 132 (40%) | <0.001 |
| Cardiovascular medication | 321 (46%) | 0 (0%) | 318 (96%) | <0.001 |
| Hypertension | 255 (36%) | 0 (0%) | 253 (76%) | <0.001 |
| Ischaemic heart disease | 48 (7%) | 0 (0%) | 47 (14%) | <0.001 |
| Diabetes mellitus | 55 (8%) | 0 (0%) | 54 (16%) | <0.001 |
| Echocardiography | ||||
| Geometry | ||||
| LV internal diameter (mm) | 48.5 (±4.3) | 48.4 (±4.2) | 48.3 (±4.3) | 0.84 |
| LVMi (g/m2) | 97.1 (±20.1) | 86.7 (±14.6) | 100.5 (±20.6) | <0.001 |
| LV hypertrophy | 151 (22%) | 0 (0%) | 86 (26%) | <0.001 |
| LAVi (mL/m2) | 28.2 (±8.4) | 24.3 (±5.7) | 31.4 (±8.9) | <0.001 |
| Doppler | ||||
| | 1.0 (±0.3) | 1.2 (±0.4) | 1.0 (±0.3) | <0.001 |
| | 7.5 (±2.2) | 6.3 (±1.5) | 8.1 (±2.4) | <0.001 |
| Deceleration time (ms) | 236.2 (±66.3) | 230.4 (±68.2) | 240.0 (±66.7) | 0.06 |
| E′sep (cm/s) | 7.1 (±1.9) | 8.1 (±1.9) | 6.6 (±1.8) | <0.001 |
| E′lat (cm/s) | 9.0 (±2.5) | 10.1 (±2.6) | 8.5 (±2.3) | <0.001 |
Categorical variables presented as counts and percentages and continuous variables as mean ± SD, except for NT-proBNP in which the median and interquartile ranges were used because the distribution was non-normal. LV, left ventricle; LVMi, LV mass index; LAVi, left atrial volume index; E, early mitral inflow velocity; A, late mitral inflow velocity; E′, early myocardial tissue velocity; E′avg, E′ averaged for septal and lateral walls; E′sep, E′ of the septal wall; E′lat, E′ of the lateral wall.
aP-value for differences between the low- and high-risk subgroups.
Effect on the prevalence of DDF by using different interpretations of the EACVI/ASE algorithm for DDF classification
| All subjects ( | Low-risk subgroup ( | High-risk subgroup ( | |
|---|---|---|---|
| (E′sep < 8) OR (E′lat < 10) OR (LAVi > 34) | 84 (82–87) | 67 (59–75) | 94 (90–96) |
| (E′sep < 8) OR (E′lat < 10) | 82 (79–85) | 65 (56–73) | 89 (85–92) |
| (E′avg < 9) OR (LAVi > 34) | 77 (73–80) | 50 (41–59) | 88 (85–92) |
| (E′lat < 10) OR (LAVi > 34) | 76 (73–79) | 54 (45–63) | 86 (82–90) |
| (E′sep < 8) OR (LAVi > 34) | 73 (70–76) | 53 (45–62) | 84 (80–88) |
| (E′avg < 9) | 71 (68–75) | 47 (38–56) | 81 (77–85) |
| (E′lat < 10) | 70 (67–74) | 51 (42–60) | 77 (72–81) |
| (E′sep < 8) | 68 (65–72) | 50 (41–59) | 78 (73–82) |
| (E′sep < 8) AND (E′lat < 10) | 57 (53–61) | 36 (28–45) | 65 (60–70) |
| (LAVi > 34) | 20 (17–23) | 5 (2–10) | 32 (27–37) |
| (E′sep < 8) AND (LAVi > 34) | 16 (13–19) | 2 (0–5) | 26 (21–31) |
| (E′avg < 9) AND (LAVi > 34) | 15 (12–18) | 2 (0–5) | 24 (20–29) |
| (E′lat < 10) AND (LAVi > 34) | 14 (12–17) | 2 (0–5) | 22 (18–27) |
| (E′sep < 8) AND (E′lat < 10) AND (LAVi > 34) | 12 (10–15) | 1 (0–4) | 20 (16–25) |
Values are percentages (95% confidence intervals).
E′, early diastolic myocardial tissue velocity; E′sep, E′ of the septal wall; E′lat, E′ of the lateral wall; E′avg, average of E′lat and E′sep; LAVi, left atrial volume index.